The Only Guide to Biotech Investing You'll Ever Need

https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/fd/09/3d/fd093d7e-caf3-4dc3-9726-763764713824/mza_10111781282278569114.jpg/600x600bb.jpg

Nanalyze

380 episodes

19 hours ago

Nanalyze is a media and research firm founded by finance professionals with decades of experience. We share insights about disruptive technology stocks in a language that is future-proof and easy to understand. Read all the Nanalyze Premium articles you'd like for free! Sign up for a 30-day trial of our monthly subscription with no strings attached: https://www.nanalyze.com/become-a-nanalyze-premium-subscriber/

Investing

Business

RSS

All content for Nanalyze is the property of Nanalyze and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Investing

Business

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/36487536/36487536-1675358932298-428eb488e367c.jpg

The Only Guide to Biotech Investing You'll Ever Need

Nanalyze

14 minutes 55 seconds

2 weeks ago

The Only Guide to Biotech Investing You'll Ever Need

The global biotech market is expected to reach roughly $6 trillion in the next decade. Opportunities like that leave our subscribers salivating, so they've asked us to help them find the best way to invest in this nascent industry. Today, we'll explore the top two biotech ETFs: XBI and IBB. It was tough to pick a winner, but one came out slightly ahead for reasons you'll see in this piece.

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/w09d9ooPGkM.